General Information of the Compound
| Compound ID |
CP0389351
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S)-1-[(E)-4-(1-benzothiophen-5-yl)-4,4-bis(4-methoxyphenyl)but-2-enyl]piperidine-3-carboxylic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H33NO4S
|
||||||||||||||||||
| Molecular Weight |
527.686
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1)C(\C=C\CN1CCC[C@@H](C1)C(O)=O)(c1ccc(OC)cc1)c1ccc2sccc2c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H33NO4S/c1-36-28-11-6-25(7-12-28)32(26-8-13-29(37-2)14-9-26,27-10-15-30-23(21-27)16-20-38-30)17-4-19-33-18-3-5-24(22-33)31(34)35/h4,6-17,20-21,24H,3,5,18-19,22H2,1-2H3,(H,34,35)/b17-4+/t24-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BCLUMDBGGSYAHR-UZJKPBDZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03285, Sodium- and chloride-dependent GABA transporter 1
Protein ID: PT03705, Sodium- and chloride-dependent GABA transporter 2
Protein ID: PT03076, Sodium- and chloride-dependent GABA transporter 3